Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rasche

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
Journal of Translational Medicine|April 23, 2020
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytesM J Steinhardt, E Wiercinska, M Pham, et al.
Cancer Research Communications|April 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical CancerSebastian O Wendel, Grant M Brooke, Changkun Hu, et al.
Leukemia|December 22, 2018
Combination of flow cytometry and functional imaging for monitoring of residual disease in myelomaL Rasche, D Alapat, M Kumar, et al.
Nature Communications|August 18, 2017
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingL Rasche, S S Chavan, O W Stephens, et al.
Leukemia|January 20, 2024
Real-world analysis of teclistamab in 123 RRMM patients from GermanyC Riedhammer, F Bassermann, B Besemer, et al.
Leukemia|February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5DC Riedhammer, M Truger, H Lee, et al.
Blood Cancer Journal|February 25, 2017
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic markerS S Chavan, J He, R Tytarenko, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Hematology|March 7, 2015
Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P)K M Kortüm, C Langer, J Monge, et al.
Journal of Translational Medicine|April 23, 2020
Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytesM J Steinhardt, E Wiercinska, M Pham, et al.
Cancer Research Communications|April 27, 2026
Targeting Cancer-Associated PCNA with AOH1996 Induces Mitotic Catastrophe and Enhances Cisplatin Therapy in Cervical CancerSebastian O Wendel, Grant M Brooke, Changkun Hu, et al.
Leukemia|December 22, 2018
Combination of flow cytometry and functional imaging for monitoring of residual disease in myelomaL Rasche, D Alapat, M Kumar, et al.
Nature Communications|August 18, 2017
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencingL Rasche, S S Chavan, O W Stephens, et al.
Leukemia|January 20, 2024
Real-world analysis of teclistamab in 123 RRMM patients from GermanyC Riedhammer, F Bassermann, B Besemer, et al.
Leukemia|February 17, 2026
The evolution to hepta-refractory myeloma involves sequential loss of CD38, BCMA and GPRC5DC Riedhammer, M Truger, H Lee, et al.
Blood Cancer Journal|February 25, 2017
Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic markerS S Chavan, J He, R Tytarenko, et al.
Pageof 3